Changes in peptide regulations under RFK Jr.'s health policy could impact companies like Hims & Hers that offer GLP-1 medications online. The FDA review scheduled for 2026 will shape opportunities for these telehealth weight loss services.
Posts published in “GLP-1”
Walmart is expanding its digital health platform to include weight management services and GLP-1 prescribing as the retail giant capitalizes on growing consumer interest in these weight-loss drugs. This move makes these medications more accessible through a major retail chain.
A new study found that people with a specific genetic variant may respond better to GLP-1 weight loss drugs like Ozempic and Wegovy. This discovery could help predict which patients will see the most success with these medications.
Doctors and patients are reporting a concerning side effect called 'Ozempic personality' - emotional flattening that makes life feel bland while taking GLP-1 medications like Ozempic and Wegovy.
Doctors and patients are noticing that GLP-1 drugs like Ozempic may cause emotional changes, with some people feeling less excited or engaged with life. This "Ozempic personality" effect is being reported across social media and in medical practices.
As demand for GLP-1 weight-loss drugs like Ozempic surges, many employers and insurance companies are struggling with the high costs. Some companies that want to offer these benefits to employees are being forced to drop coverage altogether due to expense.
Millions of Americans are experimenting with GLP-1 medications for various purposes, but scientific research hasn't caught up to understand all the effects. This widespread use is happening faster than studies can be conducted to fully evaluate safety and effectiveness.
Millions of Americans are using GLP-1 weight loss drugs like Ozempic, but scientific research hasn't caught up to understand all the effects. This widespread real-world use is happening faster than formal studies can track safety and effectiveness.